Oleoylethanolamide

fatty-acidfatty acid amide

At a glance

Best for
adults wanting appetite/weight support, accepting preliminary evidence
Typical dose
Commonly ~100–300 mg/day per product labels
Time to effect
Weeks
Main caution
Human efficacy is unproven; not a substitute for diet
Evidence strength: Low; mostly preclinical with small human studies

What is it

Oleoylethanolamide (OEA) is a naturally occurring lipid mediator produced in the gut from oleic acid that signals satiety, mainly by activating the PPAR-alpha receptor. It is sold as a supplement for appetite control and weight management. Human evidence is early and limited, with most support coming from animal and mechanistic studies.

Is it worth it for you?

Worth considering if…

  • You want to trial an appetite-modulating supplement alongside diet
  • You will track intake and weight and stop if there is no effect

Probably skip if…

  • You expect substantial weight loss on its own
  • You want proven, replicated human results
  • You are pregnant or have an eating disorder

Evidence at a glance

GoalEvidenceEffectBest fitTime
appetite control and weight managementLimitedSmall/uncertainadults using it as an adjunct to a reduced-calorie dietWeeks

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

appetite control and weight management

Supplement benefit
Limited

OEA is a well-characterized satiety signal that reduces food intake and body weight in animal models via PPAR-alpha. A small number of human studies suggest modest effects on appetite or weight when combined with diet, but trials are few, small and sometimes use related formulations. Clinical benefit in people remains preliminary.

Effect size: Small/uncertain
Time to effect: Weeks
Best fit: adults using it as an adjunct to a reduced-calorie diet
Less likely: people expecting weight loss without dietary change

Bottom line: A mechanistically sound satiety mediator with only preliminary human weight data.

Evidence is mixed

Strong animal/mechanistic data are not yet matched by robust, replicated human trials.

How to take it

Typical dose
~100–300 mg/day per label
Timing
Before meals (aligns with its satiety role)
With food
Shortly before food
How long to try
Trial 8–12 weeks and reassess

What to track

  • Appetite and portion sizes
  • Body weight
  • GI tolerance

Safety

Common side effects

Mild GI upset, Nausea

Who should avoid it

  • Pregnant or breastfeeding people
  • People with eating disorders
  • Children

Pregnancy & breastfeeding

Avoid; safety has not been established.

Choosing a product

Look for

  • Stated mg of oleoylethanolamide per serving
  • Purity and third-party testing
  • No undisclosed stimulant blends

Be skeptical of

  • Effortless fat loss
  • Clinically proven weight-loss drug
  • Appetite cure

References by claim

appetite control and weight management

  • Laleh et al., 2018PubMed (2018) link

Track Oleoylethanolamide with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.